GREB1 and neuroblastoma: Following 21 days of treatment with 20 μmol/L of tazemetostat, we observed an induction in GREB1 and SPTBN2 (Supplementary Fig. S6A and S6B), genes previously shown to be transcriptionally repressed by H3K27me3 in neuroblastoma cells (39).